Aanandjit Sunderaj
Managing Director, Brookfield Corporation, Bermuda OperationsBrookfield
Fortune Global 500View Profile →Deputy General Manager, General Counsel and Chief Compliance Officer · Sinopharm
Jin Bin is a deputy general manager, general counsel and chief compliance officer of Sinopharm. His career includes administrative and office leadership at the parent and a chairmanship of listed Sinopharm Group.
Last reviewed: Nov 6, 2026
Deputy General Manager, General Counsel and Chief Compliance Officer
Sinopharm
Last Reviewed: November 6, 2026
Jin Bin is a deputy general manager, general counsel and chief compliance officer of Sinopharm. His career includes administrative and office leadership at the parent and a chairmanship of listed Sinopharm Group.
Jin joined China National Medicines in 2005, where his work included an office business-supervisor position. In 2008, he moved to China National Pharmaceutical Group, the parent company known as Sinopharm.
His subsequent parent assignments included deputy director of the Administration Department, deputy office director and office director. He became deputy general manager in November 2022.
His operating work included production safety. At the parent’s February 26, 2025 annual safety meeting, he chaired proceedings, presented the report on 2024 work and set out the following year’s priorities. In April 2025, he added general-counsel and chief-compliance-officer responsibilities.
He was subsequently nominated as a nonexecutive director and chairman of the separately listed Sinopharm Group. Shareholders approved the appointment on December 19, 2025, succeeding Zhao Bingxiang in that subsidiary role while he retained his executive position at the parent.
Jin earned a master’s degree in business administration from Beijing Jiaotong University.